Fiscal Period | 2024 |
---|---|
Period End Date | Jun 23 |
Revenue | 1284.99 |
Total Revenue | 1284.99 |
Costof Revenue Total | 275.85 |
Gross Profit | 1009.14 |
Selling/ General/ Admin Expenses Total | 497.10 |
Depreciation/ Amortization | 55.82 |
Other Operating Expenses Total | 174.66 |
Total Operating Expense | 1003.43 |
Operating Income | 281.56 |
Interest Inc( Exp) Net- Non- Op Total | -193.90 |
Other Net | 41.32 |
Net Income Before Taxes | 303.49 |
Provisionfor Income Taxes | 63.41 |
Net Income After Taxes | 240.08 |
Net Income Before Extra Items | 240.08 |
Net Income | 240.08 |
Income Availableto Com Excl Extra Ord | 240.08 |
Income Availableto Com Incl Extra Ord | 240.08 |
Diluted Net Income | 240.08 |
Diluted Weighted Average Shares | 97.59 |
Diluted EPS Excluding Extra Ord Items | 2.46 |
DPS- Common Stock Primary Issue | 0.00 |
Diluted Normalized EPS | 2.46 |
Max Healthcare Institute Dividend | Max Healthcare Institute Bonus | Max Healthcare Institute News | Max Healthcare Institute AGM | Max Healthcare Institute Rights | Max Healthcare Institute Splits | Max Healthcare Institute Board Meetings | Max Healthcare Institute Key Metrics | Max Healthcare Institute Shareholdings | Max Healthcare Institute Profit Loss | Max Healthcare Institute Balance Sheet | Max Healthcare Institute Cashflow | Max Healthcare Institute Q2 Results | Max Healthcare Institute Q3 Results | Max Healthcare Institute Q4 Results
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks